We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Should You Retain Trupanion (TRUP) Stock in Your Portfolio?
Read MoreHide Full Article
Trupanion, Inc. (TRUP - Free Report) has been benefiting from a focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries, as well as sufficient liquidity.
Growth Projections
The Zacks Consensus Estimate for Trupanion’s 2024 earnings per share indicates an increase of 57.4% from the year-ago reported number. The consensus estimate for revenues is pegged at $1.26 billion, implying a year-over-year improvement of 13.7%.
The consensus estimate for 2025 earnings per share and revenues indicates an increase of 95.4% and 6.5%, respectively, from the corresponding 2024 estimates.
The expected long-term earnings growth rate is 39.3% compared with the industry average of 17.1%.
Zacks Rank & Price Performance
Trupanion currently carries a Zacks Rank #3 (Hold). Over the past year, the stock has gained 4.9% compared with the industry’s growth of 21.6%.
Image Source: Zacks Investment Research
Earnings Surprise History
Trupanion has a decent earnings surprise history. Its earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 43.13%.
Business Tailwinds
This provider of insurance for cats and dogs operates in a large but underpenetrated market. Management noted that less than 5% of the pets are insured in North America and a very low number across most of Europe. There is immense scope as there has been a change in the attitude of pet owners, who are increasingly focusing on pet health and well-being. TRUP is well poised for growth in a total addressable market worth $34.1 billion. The insurer envisions doubling its addressable market (defined by the number of veterinary hospitals) by the end of 2030.
Average monthly retention continues to be strong, ensuring uninterrupted revenue generation. The insurer has also been expanding globally as part of its five-year growth plan, apart from strengthening its compelling portfolio. TRUP noticed increasing contributions from European endeavors, which added about 14,400 new pets during 2023.
Its focus on introducing products bodes well for growth. Its portfolio of products comprising Chewy and Aflac, medium and low average monthly revenue per unit products Firkin and Phi Direct and products in continental Europe contributed 22% to gross new pet adds in the first quarter of 2024.
Over the long term, TRUP remains focused on growing adjusted operating income and deploying increasing amounts at high internal rates of return. The pet insurer’s five-year plan includes a 15% adjusted operating margin.
TRUP projects revenues in the range of $1.2 billion to $1.3 billion, up 14% from the 2023 level. Subscription revenues are projected between $842 million and $862 million, up 20% from 2023. Total adjusted operating income is now expected to be in the range of $100 million to $120 million, up 32% year over year.
A solid balance sheet supports investment in new product development and international expansion. Trupanion expects these investments to expand the addressable market in the long run.
TRUP has a Growth Score of A. This style score helps analyze the growth prospects of a company.
Headwinds
However, Trupanion has been incurring higher expenses over the last several years, attributable to an increase in technology and development, general and administrative, new pet acquisition expenses, depreciation and amortization. The insurer must strive to generate revenue growth higher than the rise in the magnitude of expense, or else the margin will continue to erode.
Reinsurance Group has a solid track record of beating earnings estimates in each of the trailing four quarters, the average being 19.48%. In the past year, shares of RGA have jumped 43.1%.The Zacks Consensus Estimate for RGA’s 2024 and 2025 earnings implies year-over-year growth of 5.3% and 4.9%, respectively.
RLI’s earnings surpassed estimates in three of the last four quarters and missed in one, the average surprise being 132.39%. In the past year, shares of RLI have gained 1.9%.The Zacks Consensus Estimate for RLI’s 2024 and 2025 revenues implies year-over-year growth of 18.4% and 3.8%, respectively.
NMI Holdings’ earnings surpassed estimates in each of the last four quarters, the average surprise being 8.60%. In the past year, shares of NMIH have jumped 32.5%.The Zacks Consensus Estimate for NMIH’s 2024 and 2025 revenues implies year-over-year growth of 10.6% and 7.6%, respectively.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Should You Retain Trupanion (TRUP) Stock in Your Portfolio?
Trupanion, Inc. (TRUP - Free Report) has been benefiting from a focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries, as well as sufficient liquidity.
Growth Projections
The Zacks Consensus Estimate for Trupanion’s 2024 earnings per share indicates an increase of 57.4% from the year-ago reported number. The consensus estimate for revenues is pegged at $1.26 billion, implying a year-over-year improvement of 13.7%.
The consensus estimate for 2025 earnings per share and revenues indicates an increase of 95.4% and 6.5%, respectively, from the corresponding 2024 estimates.
The expected long-term earnings growth rate is 39.3% compared with the industry average of 17.1%.
Zacks Rank & Price Performance
Trupanion currently carries a Zacks Rank #3 (Hold). Over the past year, the stock has gained 4.9% compared with the industry’s growth of 21.6%.
Image Source: Zacks Investment Research
Earnings Surprise History
Trupanion has a decent earnings surprise history. Its earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 43.13%.
Business Tailwinds
This provider of insurance for cats and dogs operates in a large but underpenetrated market. Management noted that less than 5% of the pets are insured in North America and a very low number across most of Europe. There is immense scope as there has been a change in the attitude of pet owners, who are increasingly focusing on pet health and well-being. TRUP is well poised for growth in a total addressable market worth $34.1 billion. The insurer envisions doubling its addressable market (defined by the number of veterinary hospitals) by the end of 2030.
Average monthly retention continues to be strong, ensuring uninterrupted revenue generation. The insurer has also been expanding globally as part of its five-year growth plan, apart from strengthening its compelling portfolio. TRUP noticed increasing contributions from European endeavors, which added about 14,400 new pets during 2023.
Its focus on introducing products bodes well for growth. Its portfolio of products comprising Chewy and Aflac, medium and low average monthly revenue per unit products Firkin and Phi Direct and products in continental Europe contributed 22% to gross new pet adds in the first quarter of 2024.
Over the long term, TRUP remains focused on growing adjusted operating income and deploying increasing amounts at high internal rates of return. The pet insurer’s five-year plan includes a 15% adjusted operating margin.
TRUP projects revenues in the range of $1.2 billion to $1.3 billion, up 14% from the 2023 level. Subscription revenues are projected between $842 million and $862 million, up 20% from 2023. Total adjusted operating income is now expected to be in the range of $100 million to $120 million, up 32% year over year.
A solid balance sheet supports investment in new product development and international expansion. Trupanion expects these investments to expand the addressable market in the long run.
TRUP has a Growth Score of A. This style score helps analyze the growth prospects of a company.
Headwinds
However, Trupanion has been incurring higher expenses over the last several years, attributable to an increase in technology and development, general and administrative, new pet acquisition expenses, depreciation and amortization. The insurer must strive to generate revenue growth higher than the rise in the magnitude of expense, or else the margin will continue to erode.
Stocks to Consider
Some better-ranked stocks from the insurance industry are Reinsurance Group of America, Incorporated (RGA - Free Report) , RLI Corp. (RLI - Free Report) and NMI Holdings Inc (NMIH - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Reinsurance Group has a solid track record of beating earnings estimates in each of the trailing four quarters, the average being 19.48%. In the past year, shares of RGA have jumped 43.1%.The Zacks Consensus Estimate for RGA’s 2024 and 2025 earnings implies year-over-year growth of 5.3% and 4.9%, respectively.
RLI’s earnings surpassed estimates in three of the last four quarters and missed in one, the average surprise being 132.39%. In the past year, shares of RLI have gained 1.9%.The Zacks Consensus Estimate for RLI’s 2024 and 2025 revenues implies year-over-year growth of 18.4% and 3.8%, respectively.
NMI Holdings’ earnings surpassed estimates in each of the last four quarters, the average surprise being 8.60%. In the past year, shares of NMIH have jumped 32.5%.The Zacks Consensus Estimate for NMIH’s 2024 and 2025 revenues implies year-over-year growth of 10.6% and 7.6%, respectively.